Grufity logo
Grufity logo
PEPG

PEPG - PepGen Inc. Stock Price, Fair Value and News

$1.83-0.07 (-3.68%)
Market Closed as of 28 Jul 2026, 04:00 pm ET

Price Targets

PEPG Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PEPG Price Action

Last 7 days

-13.7%

Last 30 days

7.7%

Last 90 days

18.1%

Trailing 12 Months

28.0%

PEPG RSI Chart

PEPG Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PEPG Valuation

Market Cap

126.6M

Price/Earnings (Trailing)

-1.64

EV/EBITDA

-1.11

Price/Free Cashflow

-1.64

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

PEPG Fundamentals

PEPG Earnings

Earnings (TTM)

-77.2M

Earnings Growth (Yr)

41.19%

Earnings Growth (Qtr)

3.15%

PEPG Profitability

Return on Equity

-57.63%

Return on Assets

-49.4%

Free Cashflow Yield

-61.04%

PEPG Investor Care

Shares Dilution (1Y)

111.69%

Diluted EPS (TTM)

-1.46

Revenue & Growth

How PepGen Inc. generates revenue and covers its expenses, based on the latest reported earnings.

About PepGen Inc.

PEPG
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that id in Phase I clinical trial to treat individuals with Duchenne muscular dystrophy (DMD). The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEhttps://pepgen.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES54

PepGen Inc. Frequently Asked Questions

PEPG is the stock ticker symbol of PepGen Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jul 28 2026, market cap of PepGen Inc. is 126.58 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

In the past 10 years, PepGen Inc. has provided -0.112 (multiply by 100 for percentage) rate of return.